Theranostics is revolutionizing medicine and changing healthcare as we know it. Personalized medicine is now a reality for patients around the world, with nearly 20 million nuclear medicine patient procedures performed annually in the U.S. alone.
In our video series, Beyond, Nuclear & Precision Health Solutions leaders, Mike Pintek and Shane Thrasher, talk about Cardinal Health’s role and how our Center for Theranostics Advancement in Indianapolis, Indiana, is empowering pharmaceutical innovators to accelerate the development of new diagnostics and therapeutic agents to identify, diagnose and treat diseases.
Ann: Agreement with Cardinal Health for Prostate Cancer Imaging, page-4
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.55 |
Change
-0.450(2.50%) |
Mkt cap ! $5.872B | |||
| Open | High | Low | Value | Volume |
| $17.90 | $17.95 | $17.42 | $21.96M | 1.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17117 | $17.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.57 | 2880 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |